Skip to main content

Table 1 Patient characteristics

From: Point accuracy and reliability of an interstitial continuous glucose-monitoring device in critically ill patients: a prospective study

  N = 50 N = 45
All included patients Patients included in the point accuracy analysis
Age in years, median (IQR) 65 (56-72) 65 (55-72)
Male gender, number (%) 25 (50%) 24 (53%)
Race, number (%)   
  Caucasian 45 (90%) 40 (89%)
  Black 4 (8%) 4 (9%)
  Asian 1 (2%) 1 (2%)
BMI in kg/m2, median (IQR) 24.7 (22.4-27.6) 24.4 (22.2-27.3)
Admission diagnosis, number (%)   
  Medical 31 (62%) 26 (58%)
  Emergency surgery 11 (22%) 11 (24%)
  Planned surgery 8 (16%) 8 (18%)
Planned admission, number (%) 10 (20%) 9 (20%)
History of diabetes, number (%)   
  No diabetes 39 (78%) 34 (76%)
  Diabetes, unknown treatment 2 (4%) 2 (4%)
  Diabetes treated with insulin 4 (8%) 4 (9%)
  Diabetes treated with oral agents 5 (10%) 5 (12%)
APACHE II score, median (IQR) 23 (17-26) 22 (17-25)
SAPS II, median (IQR) 46 (39-55) 46 (40-55)
ICU LOS in days, median (IQR) 9 (4-16) 11 (5-16)
Hospital LOS in days, median (IQR) 19 (10-35) 19 (11-35)
ICU mortality, number (%) 11 (22%) 10 (22%)
Hospital mortality, number (%) 15 (30%) 14 (31%)
  1. APACHE II, Acute Physiology and Chronic Health Evaluation II; BMI, body mass index; ICU, intensive care unit; IQR, interquartile range; LOS, length of stay; SAPS II, Simplified Acute Physiology Score II.